313 related articles for article (PubMed ID: 25940568)
1. Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage.
Chen KH; Wu PK; Chen CF; Chen WM
Eur Spine J; 2015 Oct; 24(10):2182-8. PubMed ID: 25940568
[TBL] [Abstract][Full Text] [Related]
2. Giant cell tumors of the sacrum--a nationwide study on midterm results in 26 patients after intralesional excision.
van der Heijden L; van de Sande MA; van der Geest IC; Schreuder HW; van Royen BJ; Jutte PC; Bramer JA; Öner FC; van Noort-Suijdendorp AP; Kroon HM; Dijkstra PD
Eur Spine J; 2014 Sep; 23(9):1949-62. PubMed ID: 24614982
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
[TBL] [Abstract][Full Text] [Related]
4. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines.
Zwolak P; Manivel JC; Jasinski P; Kirstein MN; Dudek AZ; Fisher J; Cheng EY
J Bone Joint Surg Am; 2010 Jan; 92(1):162-8. PubMed ID: 20048108
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of intravenous bisphosphonate in treatment of giant cell tumor: a case report and review of the literature.
Arpornchayanon O; Leerapun T
J Med Assoc Thai; 2008 Oct; 91(10):1609-12. PubMed ID: 18972907
[TBL] [Abstract][Full Text] [Related]
8. Local administration of zoledronic acid for giant cell tumor of bone.
Nishisho T; Hanaoka N; Miyagi R; Sakai T; Toki S; Takahashi M; Kenji E; Yasui N; Sairyo K
Orthopedics; 2015 Jan; 38(1):e25-30. PubMed ID: 25611416
[TBL] [Abstract][Full Text] [Related]
9. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
[TBL] [Abstract][Full Text] [Related]
10. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
[TBL] [Abstract][Full Text] [Related]
11. Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.
Yacob O; Umer M; Gul M; Qadir I
J Orthop Surg (Hong Kong); 2016 Apr; 24(1):88-91. PubMed ID: 27122520
[TBL] [Abstract][Full Text] [Related]
12. Locally administered zoledronic Acid therapy for giant cell tumor of bone.
Nishisho T; Hanaoka N; Endo K; Takahashi M; Yasui N
Orthopedics; 2011 Jul; 34(7):e312-5. PubMed ID: 21717996
[TBL] [Abstract][Full Text] [Related]
13. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
Agarwal MG; Gundavda MK; Gupta R; Reddy R
Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
[TBL] [Abstract][Full Text] [Related]
14. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
[TBL] [Abstract][Full Text] [Related]
15. Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement.
Gao ZH; Yin JQ; Xie XB; Zou CY; Huang G; Wang J; Shen JN
BMC Musculoskelet Disord; 2014 Oct; 15():330. PubMed ID: 25277133
[TBL] [Abstract][Full Text] [Related]
16. [Clinical studies on effect of bone cement filling on articular cartilage of the knee after curettage of giant cell tumor].
Cao W; Ye Z; Lin N; Liu M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1459-63. PubMed ID: 25826886
[TBL] [Abstract][Full Text] [Related]
17. Ethanol as a local adjuvant for giant cell tumor of bone.
Jones KB; DeYoung BR; Morcuende JA; Buckwalter JA
Iowa Orthop J; 2006; 26():69-76. PubMed ID: 16789453
[TBL] [Abstract][Full Text] [Related]
18. Retrospective cohort study of 68 sacral giant cell tumours treated with nerve-sparing surgery and evaluation on therapeutic benefits of denosumab therapy.
Lim CY; Liu X; He F; Liang H; Yang Y; Ji T; Yang R; Guo W
Bone Joint J; 2020 Feb; 102-B(2):177-185. PubMed ID: 32009426
[TBL] [Abstract][Full Text] [Related]
19. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
20. Mid- to long-term clinical outcome of giant cell tumor of bone treated with calcium phosphate cement following thorough curettage and phenolization.
Takeuchi A; Suwanpramote P; Yamamoto N; Shirai T; Hayashi K; Kimura H; Miwa S; Higuchi T; Abe K; Tsuchiya H
J Surg Oncol; 2018 May; 117(6):1232-1238. PubMed ID: 29315595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
